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IDENTIFICATION OF RESPIRATORY VIRUS IN INFANTS WITH CONGENITAL HEART DISEASE BY 
COMPARISON OF DIFFERENT METHODS
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Mônica SETSUKO(2) & Clarisse Martins MACHADO (1)
SUMMARY
Respiratory virus infections are the main cause of infant hospitalization and are potentially severe in children with congenital heart 
disease (CHD). Rapid and sensitive diagnosis is very important to early introduction of antiviral treatment and implementation of 
precautions to control transmission, reducing the risk of nosocomial infections. In the present study we compare different techniques 
in the diagnosis of respiratory viruses in CHD infants. Thirty-nine samples of nasopharyngeal aspirate were obtained from CHD 
infants with symptoms of respiratory infection. The Multiplex PCR (Seeplex® RV 12 ACE Detection) driven to the detection of 12 
respiratory viruses was compared with the direct immunofluorescence assay (DFA) and PCR, both targeting seven respiratory viruses. 
The positivity found by DFA, Multiplex and PCR was 33.3%, 51.3% and 48.7%, respectively. Kappa index comparing DFA and 
Multiplex, DFA and PCR and PCR and Multiplex PCR was 0.542, 0.483 and 0.539, respectively. The concordance between techniques 
was considered moderate. Both Multiplex PCR (p = 0.001) and PCR (p = 0.002) detected significantly more respiratory virus than 
DFA. As the performance of the tests may vary, the combination of two or more techniques may increase diagnostic sensitivity favoring 
the diagnosis of co-infections, early introduction of antiviral therapy and implementation of appropriate measures. 
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INTRODUCTION
Acute respiratory tract infections (ARTIs) usually have a benign 
course but they are still the major determinant of death in developing 
countries and the most common cause of hospitalization of infants in 
developed countries. According to the World Health Organization, 
ARTIs were the leading cause of death in children under five 
years old in 200421. Previous studies in children younger than two 
years, with respiratory symptoms and clinical risk factors such as 
congenital heart disease (CHD), showed an augmented risk of severe 
infections, as demonstrated by greater morbidity and increased length 
of hospital stay13-15. Thus, the availability of a rapid and sensitive 
viral diagnostic assay is very important to establish appropriated 
therapeutic intervention, enabling physicians to make more accurate 
treatment decisions and reducing the use of unnecessary antibiotic 
therapy. Furthermore, rapid diagnosis favors the institution of specific 
precautions to minimize the risk of nosocomial infections16. In the 
last two decades, molecular techniques are improving, such as PCR 
(Polymerase Chain Reaction) or other amplification techniques of 
nucleic acid11. PCR and its variants are increasingly being used in 
routine laboratories because they are conceptually simple techniques, 
rapid, potentially very sensitive and specific and can be automated7,9,11. 
Several studies have evaluated the performance of in-house molecular 
techniques for diagnosis of respiratory viruses (RV)2,16,19. Commercial 
kits have also been evaluated and are considered rapid, sensitive and 
specific12. Currently, Seeplex® RV 12 ACE Detection, a commercial 
Multiplex PCR based on dual priming oligonucleotide (DPO) system for 
simultaneous detection of 12 respiratory viruses, has become available 
in clinical practice3,5,8,17,22. The aim of this study was to identify the 
respiratory viruses in CHD children with respiratory symptoms and to 
compare the performance of different techniques.
MATERIAL AND METHODS
1. ETHICAL CONSIDERATIONS: The current study is part of 
an ongoing project named “Respiratory Syncytial Virus (RSV) and 
Congenital Heart Disease”, conducted at InCor - HCFMUSP (Hospital 
das Clínicas, Faculdade de Medicina, Universidade de São Paulo). The 
main project was designed to evaluate the prevalence of RSV in CHD 
children younger than four years, receiving or not RSV prophylaxis 
with palivizumab. The project was approved by the Ethics Committee of 
InCor - HCFMUSP. Respiratory samples were obtained after signature 
of the consent form by parents or guardians. 
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2. POPULATION AND SAMPLE SELECTION: We selected 39 
samples of nasopharyngeal aspirate (NPA) obtained from 35 CHD 
infants (four children had two samples) with symptoms of upper and/or 
lower respiratory tract infections, assisted at the Emergency Room and 
Pediatric Intensive Care Unit of InCor - HCFMUSP. Thirteen samples 
had tested positive by direct immunofluorescence assay (DFA), being 
five (12.8%) positive for RSV, three (7.7%) for influenza A (INF A), two 
(5.1%) positive for adenovirus (ADV), two (5.1%) for parainfluenza 3 
(PIV3) and one (2.6%) for parainfluenza 1(PIV1). The remaining 26 
samples had tested negative by DFA.
3. RESPIRATORY SAMPLES: Five milliliters of saline solution 
0.9% were instilled into each nostril and aspirated in a sterile collector. 
The samples, kept at 4 °C, were promptly sent to the laboratory and 
processed for DFA within two hours. An aliquot was stored at -70 ºC for 
subsequent PCRs (Multiplex PCR, in-house PCR and Real Time PCR).
4. DFA: The DFA using specific monoclonal antibodies (Kit Light 
DiagnosticsTM Respiratory DFA Viral Screening & Identification - 
Millipore, Bilerica, MA, USA) was performed for detection of influenza 
A and B, parainfluenza 1, 2 and 3, adenovirus and RSV in accordance 
with the manufacturer´s instructions.
5. RNA EXTRACTION AND REVERSE TRANSCRIPTION: 
RNA extraction was performed with the QIAamp® Viral RNA Mini 
Kit 250 (QIAGEN, Hilden, Germany) and the cDNA synthesis was 
performed using kit High-Capacity cDNA Reverse Transcription 
(Applied Biosystems, Foster City, CA, USA) in accordance with the 
manufacturer´s protocol. The products were stored at -70 °C before 
molecular testing. The same extraction method was used for adenovirus 
detection, and the ADV transcripts were identified.
6. MULTIPLEX PCR: The kit Seeplex® RV 12 ACE Detection 
(Seegene, Seoul, Korea), was used to detect 12 respiratory virus: ADV, 
human metapneumovirus (hMPV), coronavirus (hCoV) 229E/NL63, 
hCoV OC43/HKU1, PIV 1, 2 and 3, INF A and INF B, RSV A and B and 
rhinovirus (HRV) A/B, according to the manufacturer´s instructions with 
some modifications. GeneAmp PCR System 9700 (Applied Biosystems, 
Foster City, CA) was the thermal cycler used. Positive and negative 
controls were included in each reaction. PCR was performed with a final 
reaction volume of 20.0 µL containing 3.0 µL of cDNA. The amplified 
PCR products were separated on 2% agarose gels (Invitrogen, Carlsbad, 
CA) stained with ethidium bromide (BioAgency, São Paulo, BR). Three 
microliters of the amplified product and negative control; 1.0 µL positive 
control and 5.0 µL reference marker and ladder 100 bp (Fermentas, 
Burlington, CA) were applied into the gel. Specific fragment size was 
revealed by UV transillumination and recorded by AlphaImager® EC 
System, (Alpha Innotech Corporation, San Leandro, CA). The type of 
respiratory virus was identified by comparison with the reference specific 
fragment size provided by the manufacturer. 
7. PCR SPECIFIC FOR EACH VIRUS (PCR):
7.1.IN-HOUSE PCR: This technique was performed to detect 
adenovirus, human metapneumovirus and RSV A and B. References 
and primers are described in Table 1 with few modifications1,6,19. 
Known positive samples and DEPC water were used as positive and 
negative controls, respectively, in each reaction. Mastercycler Gradient 
Eppendorf (Eppendorf, Hamburg, Germany) was the thermal cycler 
used. The amplified PCR products were separated on 1.5% agarose gel 
(Invitrogen, Carlsbad, CA) stained with ethidium bromide (BioAgency, 
São Paulo, BR). For amplification reaction for adenovirus and human 
metapneumovirus, they were applied on gel 10.0 µL of amplified product 
and 5.0 µL of ladder 100 bp (Fermentas, Burlington, CA). For RSV 
reaction they were applied with 10.0 µL of PCR product with 2.0 µL 
of bromophenol blue. Specific fragment size was revealed as described 
above.
7.1.1. Adenovirus: Nested–PCR was performed. For first-round, the 
PCR mixture (50.0 µL) contained 3.0 µL of cDNA, 1 x reaction buffer 
(50 mM KCl, 10 mM Tris-HCl), 0.2 mM deoxynucleotide (dGTP, dATP, 
dTTP and dCTP), 1.5 mM MgCl2, 0.2 mM of each primer (hex1deg and 
hex2deg) (Table 1), Taq polimerase 2 U/reaction (Invitrogen, Carlsbad, 
CA), glycerol 4.5% and Cresol Red 0.25 µg/µL. PCR cycle conditions 
consisted of three minutes at 94 °C and 35 cycles of 30 seconds at 94 °C, 
30 seconds at 55 °C, one minute at 72 °C and a final step for five minutes at 
72 °C. For the second-round PCR, 3.0 µL of the first–round PCR product 
was used and the same conditions were applied, but another set of primers 
was used: nehex3deg (5’-GCCCGYGCMACIGAIACSTACTTC- 3’) 
and nehex4deg (5’-CCYACRGCCAGIGTRWAICGMRCYTTGTA-3’) 
(Table 1).
Table 1 
Selected primers for in-house PCR for adenovirus, human metapneumovirus and RSV
Virus Primers Sequence(5’ – 3’) Target gene Product Reference
Adenovirus
Hex1deg
Hex2deg
Nehex3deg
Nehex4deg
GCCSCARTGGKCWTACATGCACATC
CAGCACSCCICGRATGTCAAA
GCCCGYGCMACIGAIACSTACTTC
CCYACRGCCAGIGTRWAICGMRCYTTGTA
Hexon
301 bp
171 bp
ALLARD 
et al., 20011
Human 
Metapneumovirus
MPVF-F1
MPVF-R1
GAGCAAATTGAAAATCCCAGACA
GAAAACTGCCGCACAACATTTAG Fusion Protein 347 bp
 FALSEY 
et al., 20036
Respiratory 
Syncytial Virus
G267
F164 
G32
GATGCAACAAGCCAGATCAAG
GTTATGACACTGGTATACCAACC 
GCAACCATGTCCAAACACAAG
G Protein  900 bp - VSR A1.100 bp - VSR B
SULLENDER 
et al., 199319
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7.1.2. Human Metapneumovirus: PCR was conducted in a final 
reaction volume of 25.0 µL containing 5.0 µL of cDNA, 1x buffer (50 
mM KCl, 10 mM Tris-HCl), 0.2 mM deoxynucleotide (dGTP, dATP, 
dTTP and dCTP), 1.5 mM MgCl2, 0.1 µM of each primer, glycerol 4.5%, 
Cresol Red 0.25µg/µL and Taq polymerase 1 U/reaction (Invitrogen, 
Carlsbad, CA). The PCR protocol was 95 ºC for two minutes; 40 cycles 
at 94 ºC for one minute, 55 ºC for one minute and 72 ºC for one minute, 
followed by 10 minutes at 72 ºC.
7.1.3. RSV: PCR amplification was performed in a final reaction 
volume of 25.0 µL using 5.0 µL of cDNA, 1x buffer (50 mM KCl, 10 
mM Tris-HCl), 0.2 mM deoxynucleotide (dGTP, dATP, dTTP and dCTP), 
1.5 mM MgCl2, 2.0 µM of each primer and Taq polimerase 2.5 U/reaction 
(Invitrogen, Carlsbad, CA). An initial step of 94 ºC for two minutes was 
performed, followed by a total of 35 cycles at 94 ºC for one minute, 
65 ºC for one minute and 72 ºC for one minute, with final cycle at 72 ºC 
for seven minutes.
7.2. REAL TIME PCR: This technique was performed to detect 
influenza A and B and parainfluenza 3. References, primers and probes 
used are listed in Table 2, with few modifications18,20. Known positive 
samples and DEPC water were used as positive and negative controls, 
respectively, in each reaction. Amplification and detection was realized 
using ABI 7300 Real Time PCR System (Applied Biosystem, Foster 
City, California, USA).
7.2.1. Influenza: For INF A, one reaction (25.0 µL) was carried out 
with 5.0 µL of cDNA, 1x TaqMan® Universal PCR Master Mix (Applied 
Biosystems, Foster City, California), 0.9 µM of primer INFA-1, 0.45 µM 
of each primer INFA-2 and 3 and 0.1 µM of probe. Thermal conditions 
and the protocol for INF B were conducted according to VAN ELDEN 
et al., 200120.
7.2.2. Parainfluenza 3: PCR was conducted in a final reaction 
volume of 25.0 µL with 3.0 µL of cDNA, 1x TaqMan® Universal PCR 
Master Mix (Applied Biosystems, Foster City, California), 0.3 µM of 
each primer and 0.2 µM of probe. PCR cycle conditions consisted of two 
minutes at 50 °C and followed by 10 minutes at 95 °C and 45 cycles of 15 
seconds at 95 ºC and one minute at 60 ºC. PIV 3 primers were described by 
SOUZA (Experimental Research Center, IIEP, Albert Einstein Hospital, 
unpublished data, personal communication)18. 
8. STATISTICAL ANALYSIS: Positive results for hCoV 229E/
NL63, hCoV OC43/HKU1 and HRV A/B identified by Multiplex PCR 
(Seeplex) were not considered in the comparison between techniques. 
Kappa index was used to compare DFA, Multiplex PCR and PCR. 
PCR was considered the gold standard for comparison between 
techniques. Statistical analysis was performed using SPSS software, 
version 15.0.
RESULTS
A total of 39 samples of nasopharyngeal aspirate were taken from 
35 infants with CHD and symptoms of respiratory infection. Of these, 
25 (64.1%) tested positive by at least one of the techniques. Thirteen 
samples (33.3%) were positive for DFA, 20 (51.3%) were positive for 
Multiplex PCR and 19 (48.7%) for PCR (Table 3). 
As shown in Table 3, DFA and Multiplex PCR showed greater 
concordance, with 30 (77%) concordant results, being 18 (46.2%) 
negative and 12 (30.8%) positive (Kappa = 0.542). The greatest 
concordance between these techniques occurred in the diagnosis of RSV 
and the smallest concordance in the diagnosis of ADV. PCR and DFA 
showed 29 (74.4%) concordant results, with 18 (46.2%) negative and 
11 (28.2%) positive (Kappa = 0.483). Equally, RSV diagnosis had the 
greatest concordance and ADV the smallest concordance. Finally, PCR 
and Multiplex PCR showed 15 (38.5%) negative and positive concordant 
results (Kappa = 0.539). The greatest concordance was observed in the 
diagnosis of ADV and smallest in the diagnosis of RSV.
Considering PCR as gold standard, the sensitivity and specificity of 
DFA were 57.9% and 90.0%, respectively, with kappa index 0.483 (p = 
0.002). Regarding Multiplex PCR, the sensitivity and specificity were 
78.9% and 75.0%, respectively, with kappa index 0.539 (p = 0.001).
The RVs more frequently identified were RSV and adenovirus, 
considering all techniques. Table 4 shows the positivity of each technique 
according to the respiratory virus analyzed.
Multiplex PCR and PCR detected eight and five co-infections, 
respectively (Table 5). Only two showed concordance in both techniques: 
ADV and human metapneumovirus, and ADV and parainfluenza 3. No 
co-infection was detected by DFA.
Table 2
Selected primers and probes for TaqMan amplification of viral RNA from Influenza viruses A and B and Parainfluenza 3
Virus Primers or Probes Sequence(5’ – 3’) Target gene Reference
Influenza A
INFA-1
INFA-2
INFA-3
INFA probe
GGACTGCAGCGTAGACGCTT
CATCCTGTTGTATATGAGGCCCAT
CATTCTGTTGTATATGAGGCCCAT
6FAM-CTCAGTTATTCTGCTGGTGCACTTGCCA-6TAMRA
Matrix protein VAN ELDEN 
et al., 200120
Influenza B INFB-1INFB-2
INFB probe
AAATACGGTGGATTAAATAAAAGCAA
CCAGCAATAGCTCCGAAGAAA
6FAM-CACCCATATTGGGCAATTTCCTATGGC-6TAMRA
Hemagglutinin VAN ELDEN 
et al., 200120
Parainfluenza 3
PIV3-1
PIV3-2
PIV3 probe
CCAGGGATATAYTAYAAAGGCAAAA
CCGGGRCACCCAGTTGTG
 6FAM-TGGRTGTTCAAGACCTCCATAYCCGAGAAA-NFQ
Hemagglutinin- 
Neuraminidase SOUZA,
18
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Table 3 
Concordance between different techniques and kappa index
Multiplex PCR
Total Kappa index
Positive Negative
DFA Positive 12 (30.8%) 1 (2.6%) 13 (33.3%)
Negative 8 (20.5%) 18 (46.2%) 26 (66.7%) 0.542
Total 20 (51.3%) 19 (48.7%) 39 (100.0%)
PCR specific for each virus
Total Kappa index
Positive Negative
DFA Positive 11 (28.2%) 2 (5.1%) 13 (33.3%)
Negative  8 (20.5%) 18 (46.2%) 26 (66.7%) 0.483
Total 19 (48.7%) 20 (51.3%) 39 (100.0%)
PCR specific for each virus
Total Kappa index
Positive Negative
Multiplex PCR Positive 15 (38.5%) 5 (12.8%) 20 (51.3%)
Negative 4 (10.2%) 15 (38.5%) 19 (48.7%) 0.539
Total 19 (48.7%) 20 (51.3%) 39 (100.0%)
Table 4
Proportion of viral positivity detected according DFA, Multiplex PCR and PCR specific for each virus 
Techniques
Respiratory Viruses
ADV RSV A RSV B INF A INF B PIV 1 PIV 2 PIV 3 hMPV
DFA 2/39 (5.1%) 5/39 (12.8%) 3/39 (7.7%) 0% 1/39 (2.6%) 0 2/39 (5.1%) NR
Multiplex 
PCR 8/39 (20.5%) 3/39 (7.7%) 6/39 (15.4%) 4/39 (10.3%) 0% 4/39 (10.3%) 0 4/39 (10.3%) 2/39 (5.1%)
PCR specific 
for each virus 10/39 (25.6%) 3/39 (7.7%) 1/39 (2.6%) 3/39 (7.7%) 0% NR NR 3/39 (7.7%) 4/39 (10.3%)
ADV: Adenovirus; RSV: Respiratory Syncytial Virus; INF: Influenza; PIV: Parainfluenza; hMPV: Human Metapneumovirus; NR: Not realized.
Table 5
Respiratory virus co-infections according to Multiplex PCR assay and PCR specific for each virus 
Co-infections Multiplex PCR [Sample number] PCR specific for each virus 
[Sample number]
ADV + hMPV 1 [43] 2 [43; 48] 
ADV + PIV 3 1 [15] 1 [15]
ADV + PIV 1 1 [2] 0 (PIV 1 not done)
ADV + RSV B 1 [46] 1 [22]
INF A + RSV A 1 [41] 1 [42]
ADV + INF A + RSV A 1 [14] 0
ADV + PIV 1 + RSV B 1 [22] 0 (PIV 1 not done)
PIV 1 + RSV A + RSV B 1 [23] 0 (PIV 1 not done)
ADV: Adenovirus; RSV: Respiratory Syncytial Virus; INF: Influenza; PIV: Parainfluenza; hMPV: Human Metapneumovirus.
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DISCUSSION
Viral respiratory tract infections may be potentially severe, especially 
in children with congenital heart disease13-15; so it is essential a sensitive 
and rapid test to detect pathogens.
In this study, the use of three different techniques favored the 
detection of at least one respiratory virus in approximately 64% of 
samples.
In the diagnosis of respiratory viruses, DFA has been more frequently 
used in several clinical laboratories, as the technique can provide specific 
diagnosis in a few hours, so several commercial kits should be on 
hand. However, the monoclonal antibodies available are directed to a 
limited number of viruses, excluding the ones most recently discovered. 
Moreover, this technique has a lower sensitivity when compared with 
molecular techniques11. Also, the reader subjectivity, the need for 
specimens with the appropriate number of cells, and the impossibility 
of automation are other problems associated with the DFAs.
Recently, a new molecular technique has been used, based on a 
dual priming oligonucleotide (DPO) system, developed by CHUN et 
al.4. The system uses a primer that contains two regions joined by a 
polydeoxyinosine link that allow a wide range of annealing temperatures, 
providing high specificity, and preventing false positive results. 
As observed in other comparative studies, Multiplex PCR based on 
DPO system has been considered a sensitive8,17,22 and specific technique8 
for detection of multiple respiratory viruses and consequently, an effective 
tool for use in a clinical laboratory5, favoring early diagnosis.
In the present study, both Multiplex and PCR specific detected 
significantly more respiratory viruses in comparison to DFA (p < 0.0001 
and p = 0.002, respectively). 
Other studies have shown similar results. Multiplex PCR and DFA 
positivity was 51.3% and 33.3%, respectively, similar to those found by 
YOO et al. (56% and 33%)22. However, the 48.7% positivity of our PCR 
techniques (in-house and Real Time) was lower than the 69% positivity 
obtained by BRUIJNESTEIJN VAN COPPENRAET et al.3 who used 
Real Time PCR.
According to kappa index, concordance between tests was considered 
moderate. Among the 13 positive samples by DFA only one (influenza 
A) did not agree with any molecular technique. All other positive results 
were concordant at least with Multiplex PCR. We cannot be sure about 
RSV type concordance because DFA does not discriminate between 
RSV A and RSV B.
Among the 26 negative samples by DFA, seven (26.9%) and six 
(23.1%) samples were positive by Multiplex PCR and PCR, respectively. 
These results were expected since molecular techniques have a higher 
capability of detection even in clinical samples with lower titer of 
virus8,10. Also, several co-infections were detected using molecular 
techniques but not by DFA. Multiplex PCR detected eight co-infections, 
accounting for 40% of positive samples. Other studies have found 
between 9 to 18% of co-infections with the same technique3,8,17,22. PCR 
diagnosed five (26.3% of positive samples) co-infections. Probably, 
DFA has not been detected due to low sensitivity of the technique, 
especially in relation to adenovirus, although some authors attribute this 
to the subjective IF readouts of this technique11. The ability to detect 
co-infections is extremely important for providing data for studies of 
clinical importance of co-infections, to investigate whether certain 
individual groups are at greater risk for co-infections or whether they 
result in a poorer outcome for the patient. In addition, multiplex tests 
can contribute to understanding the epidemiology of viral infections 
and provide new information on seasonality, geographical distribution 
and risk groups11.
In the present study, the concordance between tests was considered 
moderate and molecular techniques detected significantly more virus 
than DFA. Multiplex PCR is a faster and less laborious technique than 
PCR specific for each virus, because it is able to detect 12 respiratory 
viruses in only two amplification reactions. In contrast, PCR would 
require one reaction for each virus. On the other hand, Multiplex PCR 
requires greater care in gel load and electrophoresis for a discriminating 
interpretation of the results.
In conclusion, the use of more than one technique can increase 
the sensitivity in respiratory virus detection. The Seeplex® RV 12 ACE 
Detection kit showed a good performance and may contribute to early 
diagnosis of RV infections, especially in the presence of co-infections and 
in patients at higher risk of complications. Other studies are necessary 
to demonstrate the cost-effectiveness of this assay in comparison with 
other rapid techniques. 
RESUMO
Identificação de vírus respiratórios em crianças com cardiopatia 
congênita por comparação de diferentes métodos
Infecções respiratórias virais são a principal causa de hospitalização 
infantil e podem ser extremamente graves em crianças com cardiopatia 
congênita. O diagnóstico rápido e sensível é importante para a introdução 
precoce de tratamento antiviral e implantação de precauções para controle 
da transmissão, reduzindo o risco de infecções nosocomiais. Neste estudo, 
comparamos o desempenho de diferentes técnicas no diagnóstico de 
vírus respiratórios em crianças com cardiopatia congênita e sintomas 
respiratórios. Trinta e nove amostras de aspirado de nasofaringe foram 
obtidas de crianças com sintomas de infecção respiratória. Ensaio de 
PCR Multiplex que detecta 12 vírus respiratórios (Seeplex® RV 12 
ACE Detection) foi comparado à Imunofluorescência Direta (IFD) e à 
PCR específica, ambas direcionadas a sete vírus. A positividade da IFD 
foi 33,3%, do Multiplex foi 51,3% e da PCR 48,7%. O índice kappa 
comparando IFD e Multiplex, IFD e PCR, e PCR e Multiplex foi, 
respectivamente, 0,542, 0,483 e 0,539, sendo a concordância considerada 
moderada. O Multiplex e a PCR detectaram significantemente mais vírus 
que a IFD (p < 0,0001 e 0,002, respectivamente). Como o desempenho dos 
testes varia o uso de mais de uma técnica pode aumentar a sensibilidade 
diagnóstica favorecendo a introdução precoce de terapia antiviral e 
implantação de medidas profiláticas. 
ACKNOWLEDGEMENTS
The study was partially supported by Abbott. Kit Seeplex was kindly 
provided by Bioeasy Diagnóstica.
KANASHIRO, T.M.; VILAS BOAS, L.S.; THOMAZ, A.M.; TOZETTO-MENDOZA, T.R.; SETSUKO, M. & MACHADO, C.M. - Identification of respiratory virus in infants with congenital 
heart disease by comparison of different methods. Rev. Inst. Med. Trop. Sao Paulo, 53(5): 241-6, 2011.
246
REFERENCES
 1. Allard A, Albinsson B, Wadell G. Rapid typing of human adenoviruses by a general PCR 
combined with restriction endonuclease analysis. J Clin Microbiol. 2001;39:498-505.
 2. Bharaj P, Sullender WM, Kabra SK, Mani K, Cherian J, Tyagi V, et al. Respiratory 
viral infections detected by multiplex PCR among pediatric patients with lower 
respiratory tract infections seen at an urban hospital in Delhi from 2005 to 2007. 
Virol J. 2009;6:89.
 3. Bruijnesteijn van Coppenraet LE, Swanink CM, van Zwet AA, Nijhuis RH, Schirm J, 
Wallinga JA, et al. Comparison of two commercial molecular assays for simultaneous 
detection of respiratory viruses in clinical samples using two automatic electrophoresis 
detection systems. J Virol Methods. 2010;169:188-92.
 4.  Chun JY, Kim KJ, Hwang IT, Kim YJ, Lee DH, Lee IK, et al. Dual priming 
oligonucleotide system for the multiplex detection of respiratory viruses and SNP 
genotyping of CYP2C19 gene. Nucleic Acids Res. 2007; 35:e40.
 5. Drews SJ, Blair J, Lombos E, DeLima C, Burton L, Mazzulli T, et al. Use of the Seeplex 
RV detection kit for surveillance of respiratory viral outbreaks in Toronto, Ontario, 
Canada. Ann Clin Lab Sci. 2008;38:376-9.
 6. Falsey AR, Erdman D, Anderson LJ, Walsh EE. Human metapneumovirus infections in 
young and elderly adults. J Infect Dis. 2003;187:785-90.
 7. Harrison TJ. The polymerase chain reaction--a time of transition from research to routine. 
J Clin Pathol. 1998;51:491-2.
 8. Kim SR, Ki CS, Lee NY. Rapid detection and identification of 12 respiratory viruses using 
a dual priming oligonucleotide system-based multiplex PCR assay. J Virol Methods. 
2009;156:111-6.
 9. Klapper PE, Jungkind DL, Fenner T, Antinozzi R, Schirm J, Blanckmeister C. Multicenter 
international work flow study of an automated polymerase chain reaction instrument. 
Clin Chem. 1998;44:1737-9.
 10. Liolios L, Jenney A, Spelman D, Kotsimbos T, Catton M, Wesselingh S. Comparison of 
a multiplex reverse transcription-PCR-enzyme hybridization assay with conventional 
viral culture and immunofluorescence techniques for the detection of seven viral 
respiratory pathogens. J Clin Microbiol. 2001;39:2779-83.
 11. Mahony JB. Detection of respiratory viruses by molecular methods. Clin Microbiol Rev. 
2008; 21:716-47.
 12. Marshall DJ, Reisdorf E, Harms G, Beaty E, Moser MJ, Lee WM, et al. Evaluation of a 
multiplexed PCR assay for detection of respiratory viral pathogens in a public health 
laboratory setting. J Clin Microbiol. 2007;45:3875-82.
 13. Medrano C, Garcia-Guereta L, Grueso J, Insa B, Ballesteros F, Casaldaliga J, et al. 
Respiratory infection in congenital cardiac disease. Hospitalizations in young children 
in Spain during 2004 and 2005: the CIVIC Epidemiologic Study. Cardiol Young. 
2007;17:360-71.
 14. Medrano López C, García-Guereta Silva L. Infecciocnes respiratorias y cardiopatías: dos 
estaciones del studio CIVIC. An Pediatr (Barc). 2007;67:329-36.
 15. Medrano López C, García-Guereta Silva L, Lirio Casero J, García Pérez J, Grupo CIVIC 
Grupo de Trabajo de Infecciones de la Sociedad Española de Cardiología Pediátrica y 
Cardiopatías Congénitas. Infecciones respiratorias, syndrome de Down y cardiopatías 
congenitas: estudio CIVIC 21. An Pediatr (Barc). 2009;71:38-46.
 16. Reis AD, Fink MC, Machado CM, Paz JPJr, Oliveira RR, Tateno AF, et al. Comparison of 
direct immunofluorescence, conventional cell culture and polymerase chain reaction 
techniques for detecting respiratory syncytial virus in nasopharyngeal aspirates from 
infants. Rev Inst Med Trop Sao Paulo. 2008;50:37-40.
 17. Roh KH, Kim J, Nam MH, Yoon S, Lee CK, Lee K, et al. Comparison of the Seeplex 
reverse transcription PCR assay with the R-mix viral culture and immunofluorescence 
techniques for detection of eight respiratory viruses. Ann Clin Lab Sci. 2008;38:41-6.
 18. Souza AV. Experimental Research Center, IIEP, Albert Einstein, unpublished data, personal 
communication. São Paulo.
 19. Sullender WM, Sun LR, Anderson LJ. Analysis of respiratory syncytial virus genetic-
variability with amplified cDNAs. J Clin Microbiol. 1993;31:1224-31.
 20. van Elden LJR, Nijhuis M, Schipper P, Schuurman R, van Loon AM. Simultaneous 
detection of influenza viruses A and B using real-time quantitative PCR. J Clin 
Microbiol. 2001;39:196-200.
 21. WHO. The global burden of disease. 2004 update. Geneva: World Health Organization; 
2008.
 22. Yoo SJ, Kuak EY, Shin BM. Detection of 12 respiratory viruses with two-set multiplex 
reverse transcriptase-PCR assay using a dual priming oligonucleotide system. Korean 
J Lab Med. 2007;27:420-7.
 Received: 1 April 2011
 Accepted: 22 August 2011
